Differential roles of microglia and monocytes in the inflamed central nervous system
Open accessAbstract
In the human disorder multiple sclerosis (MS) and in the model experimental autoimmune encephalomyelitis (EAE), macrophages predominate in demyelinated areas and their numbers correlate to tissue damage. Macrophages may be derived from infiltrating monocytes or resident microglia, yet are indistinguishable by light microscopy and surface phenotype. It is axiomatic that T cell–mediated macrophage activation is critical for inflammatory demyelination in EAE, yet the precise details by which tissue injury takes place remain poorly understood. In the present study, we addressed the cellular basis of autoimmune demyelination by discriminating microglial versus monocyte origins of effector macrophages. Using serial block-face scanning electron microscopy (SBF-SEM), we show that monocyte-derived macrophages associate with nodes of Ranvier and initiate demyelination, whereas microglia appear to clear debris. Gene expression profiles confirm that monocyte-derived macrophages are highly phagocytic and inflammatory, whereas those arising from microglia demonstrate an unexpected signature of globally suppressed cellular metabolism at disease onset. Distinguishing tissue-resident macrophages from infiltrating monocytes will point toward new strategies to treat disease and promote repair in diverse inflammatory pathologies in varied organs.
AI snapshot
Written from the paper’s full text.
TL;DR
Using dual reporter mice and serial block-face scanning electron microscopy, this study shows that monocyte-derived macrophages (MDMs) initiate demyelination at EAE onset, often at nodes of Ranvier, while microglia-derived macrophages (MiDMs) clear debris and show a suppressed metabolic gene signature. Expression profiling further indicates that MDMs and MiDMs have distinct effector programs despite sharing the same inflammatory CNS environment.
Key findings
- At EAE onset, MDMs and MiDMs were present in equal numbers; MiDM expansion began at peak, and at recovery MiDMs returned near preonset numbers while MDM frequency continued to decline.
- Most axoglial units (55/75; 73%) contacted both MDMs and MiDMs, but where only one myeloid type was present (20/75; 27%), nearly all were MDMs (18/20); 2–3 MDMs attached to each of 18/20 (90%) such units.
- MDMs contacted nodes of Ranvier in 7/75 (9%) axoglial units and showed invasive/demyelinating behavior; no MiDMs contacted nodes of Ranvier. In CCR2-deficient mice, demyelination was significantly reduced at EAE onset.
- MDM-enriched genes more often encoded effector functions than MiDM-enriched genes (18/28; 64.3% vs. 18/48; 37.5%), and MiDMs showed down-regulation of metabolic, activation, phagocytosis, and reactive oxygen species–related functions at onset.
Methods
- EAE was induced with MOG35–55 in Ccr2rfp/+::Cx3cr1gfp/+ and Ccr2rfp/rfp::Cx3cr1gfp/+ mice; CNS mononuclear cells were analyzed by flow cytometry and sorted as F4/80+RFP+ MDMs or F4/80+GFP+ MiDMs.
- Confocal 3D morphometry and serial block-face scanning electron microscopy (SBF-SEM) were used to distinguish MDMs from MiDMs and quantify their relationships to axoglial units, nodes of Ranvier, myelin debris, and demyelination.
- nCounter digital multiplexed gene expression of 179 inflammation-related genes was performed on naive microglia/monocytes and sorted MiDMs/MDMs across EAE onset, peak, and recovery, with hierarchical clustering, k-means clustering, and Ingenuity IPA pathway analysis.
Limitations
- The paper states that the study focused on a single pathogenically relevant time point, EAE onset, so it could not decipher the phenotypic fate of infiltrated monocytes.
- The authors state that conclusions should not be generalized beyond the present disease paradigm, noting that other models such as spinal cord contusion include Ly6Clow/CX3CR1gfp monocytes that are highly pathogenic.
- Evident from the text: the ultrastructural criteria used to distinguish MDMs and MiDMs may not be universally present in other pathological circumstances, and the findings are from mouse EAE rather than direct human MS tissue.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
26 of 47 cited sources checked · 9 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Microglia derive from yolk-sac progenitors during embryogenesis.
“Microglia and monocytes are ontogenetically distinct: microglia derive from yolk-sac progenitors during embryogenesis (Ginhoux et al., 2010; Schulz et al., 2012)”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
In MS autopsy tissues, prominent macrophage accumulation correlates with active demyelination.
“In MS autopsy tissues, prominent macrophage accumulation correlates with active demyelination (Ferguson et al., 1997; Trapp et al., 1998).”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
EAE models inflammatory aspects of multiple sclerosis.
“In EAE, which models inflammatory aspects of MS (Williams et al., 1994; Ransohoff, 2012), macrophages dominate the inflammatory infiltrates and their numbers correlate to EAE severity (Huitinga et al., 1990, 1993; Ajami et al., 2011).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Williams et al., 1994
- cites Ransohoff, 2012 source
- Premisecitation
It is estimated that 30-50% of activated macrophages in active MS lesions derive from microglia.
“Based on kinetics of cell accumulation and differential marker expression, it’s estimated that 30–50% of activated macrophages in active MS lesions derive from microglia (Brück et al., 1995; Trebst et al., 2001).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Brück et al., 1995
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Trebst et al., 2001 source
The section on hematogenous monocytes and resident microglia during early demyelination (page unavailable) supports a microglial contribution, but estimates that 58–75% of CD68-positive phagocytes in early-active zones most plausibly represent resident microglia—not 30–50%. The paper does not give the claimed percentage for activated macrophages across active MS lesions. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
CCR2 is essential for monocyte recruitment to CNS tissues during immune-mediated inflammation.
“CCR2 is essential for monocyte recruitment to CNS tissues during immune-mediated inflammation (Fife et al., 2000; Izikson et al., 2000; Savarin et al., 2010).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites Fife et al., 2000 source
- cites Izikson et al., 2000 source
The Results and Discussion report that CCR2-deficient mice did not develop the CNS infiltrates seen in wild-type mice with experimental autoimmune encephalomyelitis, and suggest that CCR2 signaling is needed to recruit monocytes into the brain and spinal cord. The claim omits that this evidence comes from a mouse model and states the proposed recruitment mechanism as a general requirement during immune-mediated CNS inflammation. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites Savarin et al., 2010 source
The Discussion (page unavailable) reports a drastic reduction in CNS monocytes in CCR2-deficient mice during JHMV infection. That supports a role for CCR2 in monocyte recruitment during viral encephalitis, but does not establish that CCR2 is essential across immune-mediated CNS inflammation generally. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
In Ccr2rfp/rfp::Cx3cr1gfp/+ mice, MDMs were virtually absent from inflamed EAE tissues and replaced in large part by neutrophils.
“To address the role of MDMs in demyelination at EAE onset, we investigated clinical characteristics in relation to node pathology and demyelination in Ccr2rfp/rfp::Cx3cr1gfp/+ mice in which MDMs were virtually absent from inflamed EAE tissues and replaced in large part by neutrophils (Saederup et al., 2010).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Saederup et al., 2010 source
The Discussion (page unavailable) says Ly6Chi monocytes were virtually absent from the CNS of these mice and that neutrophils replaced them. The Results section on CD115+ infiltration reports markedly fewer monocytes/macrophages, but also says Ly6Clo cells remained; it does not establish that all monocyte-derived macrophages (MDMs) were virtually absent. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
The study described transcription factors and miRNAs characteristic of microglia in healthy brain but not in peripheral monocytes.
“The study described transcription factors and miRNAs characteristic of microglia in healthy brain but not in peripheral monocytes.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Butovsky et al., 2014 source
- Premisecitation
The detailed profiling after separating cells via CD45dim status showed distinct mRNA, miRNA, and protein expression by microglia as compared with infiltrating monocytes or neuroepithelial brain cells.
“The detailed profiling after separating cells via CD45dim status showed distinct mRNA, miRNA, and protein expression by microglia as compared with infiltrating monocytes or neuroepithelial brain cells (Butovsky et al., 2014).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Butovsky et al., 2014 source
The Results (‘Identification of a unique microglial signature’; page not provided) report distinct gene and protein expression in CD11b+CD45Low microglia versus splenic Ly6C+ monocytes. The paper also compares microglial genes and miRNAs with astrocytes, oligodendrocytes and neurons, but does not report a protein-expression comparison with those CNS cells. The monocytes in the principal profiling comparison were isolated from spleen, not identified as infiltrating cells in the brain. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
SBF-SEM would exhibit advantages for spatial resolution required for characterizing relationships of myeloid cells to axoglial units during the inflammatory demyelinating process at EAE onset.
“SBF-SEM would exhibit advantages for spatial resolution (Denk and Horstmann, 2004) required for characterizing relationships of myeloid cells to axoglial units during the inflammatory demyelinating process at EAE onset.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Denk and Horstmann, 2004 source
- Interpretationcitation
Brisk microglial proliferation may have accelerated a gradual return toward a homeostatic expression profile, as suggested by MiDM up-regulation of fos, jun, myc, and CSF1 at disease onset.
“Brisk microglial proliferation (Ajami et al., 2011) may have accelerated a gradual return toward a homeostatic expression profile, as suggested by MiDM up-regulation of fos, jun, myc, and CSF1 (Wei et al., 2010) at disease onset.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Ajami et al., 2011 source
- cites Wei et al., 2010 source
The Introduction (page not provided) identifies CSF-1 as a regulator of mononuclear-phagocyte proliferation and microglial development, supporting the relevance of CSF1 to the proposed proliferation. It does not report MiDM up-regulation of fos, jun, myc, or CSF1 at disease onset, or a return to a homeostatic expression profile. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Findingcitation
MiDM gene expression during the course of EAE did not correspond to the M1/M2 pattern of peripheral macrophage responses to infection or tissue injury.
“MiDM gene expression during the course of EAE did not correspond to the M1/M2 pattern of peripheral macrophage responses to infection or tissue injury.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Chiu et al., 2013 source
The Results section ('SOD1G93A microglia differ significantly from LPS induced microglia and M1 or M2 macrophages'; page unavailable) finds that microglia in an ALS mouse model did not show an M1 or M2 bias during disease progression. This supports the general M1/M2 comparison, but the paper examines resident microglia in ALS, not MiDM gene expression during EAE. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Microglia are uniformly CX3CR1+ from early embryonic time points through adulthood.
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
Quote in the paperSubstantial claim1 of 3 sources checked- cites Cardona et al., 2006 source
- cites Ginhoux et al., 2010 source
The passage on developmental markers (section labeled Abstract; page unavailable) identifies CX3CR1 as a microglial marker and reports CX3CR1-expressing myeloid cells in the developing brain from E9.5. It does not establish that all microglia express CX3CR1 uniformly at every stage through adulthood. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites Schulz et al., 2012 source
- Premisecitation
The authors characterized resident microglia by profiling mRNA, miRNA, and protein in comparison with infiltrated brain macrophages, nonmicroglial resident brain cells, and peripheral macrophages.
“we characterized resident microglia by profiling mRNA, miRNA, and protein in comparison with infiltrated brain macrophages, nonmicroglial resident brain cells, and peripheral macrophages (Butovsky et al., 2014).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Butovsky et al., 2014 source
- Interpretationcitation
These findings partially explain a divergent response of these two cell types to the same stimuli.
“These findings partially explain a divergent response of these two cell types to the same stimuli (Butovsky et al., 2014).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Butovsky et al., 2014 source
The Results (Identification of a unique microglial signature; page unavailable) show substantial molecular differences between microglia and monocytes, which could help explain different responses. The cited paper does not establish that the two cell types respond divergently to the same stimuli; its reported stimulation experiments concern microglia rather than a direct comparison between the cell types. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
CCR2+Ly6C+ cells constitute the vast majority of infiltrating monocytes at EAE onset.
“CCR2+Ly6C+ cells constitute the vast majority of infiltrating monocytes at EAE onset (Saederup et al., 2010; Mizutani et al., 2012).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Saederup et al., 2010 source
The Results (Figure 4D) report that 88% of CD115+ monocyte-lineage cells in the CNS were Ly6Chi, and another Results passage (Figure 4E) identifies this subset as CCR2+. These measurements were made at peak EAE severity, not at EAE onset, so the cited paper does not establish the claim's timing. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Mizutani et al., 2012 source
The Results section identifies CCR2+ inflammatory Ly6Chi monocytes and describes classical infiltrating monocytes as CCR2+. It does not establish that CCR2+Ly6C+ cells make up the vast majority of infiltrating monocytes at EAE onset. The reported 90 ± 3.5% concerns peripherally derived cells among CD45hi cells at peak EAE, not the claimed monocyte subset at onset; page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Findingown data
Microglia clear debris in EAE.
“Phagocytic monocyte-derived macrophages associate with the nodes of Ranvier and initiate demyelination while microglia clear debris and display a suppressed metabolic gene signature in EAE.”
Quote in the paperSubstantial claim - Findingown data
Flow cytometry demonstrated distinct expression of RFP and GFP by F4/80+/CD45high MDMs and F4/80+/CD45dim MiDMs, respectively, in Ccr2rfp/+::Cx3cr1gfp/+ spinal cords at disease onset.
“Using cells isolated from Ccr2rfp/+::Cx3cr1gfp/+ spinal cords at disease onset, flow cytometry demonstrated distinct expression of RFP and GFP by F4/80+/CD45high MDMs and F4/80+/CD45dim MiDMs, respectively (Fig. 1 B).”
Quote in the paperSubstantial claim - Findingown data
At onset of EAE, two pools of CD11b+ mononuclear phagocytic cells, putative red MDMs and green MiDMs, predominated in spinal cord.
“At onset of EAE, two pools of CD11b+ mononuclear phagocytic cells (putative red MDMs and green MiDMs) predominated in spinal cord (Fig. 1 A), indicating that fluorochrome markers could be distinguished at this time point.”
Quote in the paperSubstantial claim - Findingown data
MDMs and MiDMs showed equal numbers at disease onset when explosive MDM accumulation occurred.
“Enumeration of cells recovered from cell sorting using F4/80+RFP+ as MDMs gate and F4/80+GFP+ as MiDMs gate indicated that MDMs and MiDMs showed equal numbers at disease onset when explosive MDM accumulation occurred.”
Quote in the paperSubstantial claim - Findingnone given
Microglia display a suppressed metabolic gene signature in EAE.
“Phagocytic monocyte-derived macrophages associate with the nodes of Ranvier and initiate demyelination while microglia clear debris and display a suppressed metabolic gene signature in EAE.”
Quote in the paperSubstantial claim - Findingown data
Green group genes, up-regulated at onset and transiently further up-regulated at peak, were comprised mainly of complement-system elements, mononuclear cell-specific chemokines, proliferation related genes, and acute inflammation-related genes.
“Green group genes, up-regulated at onset and transiently further up-regulated at peak, were comprised mainly of complement-system elements (C3aR1; C4a, C1qa, C1qa, C3, and Cfb); mononuclear cell–specific chemokines (CCl2, 3, 4, 5, 7, and CXCL9); proliferation related genes (fos, jun, myc, and CSF1); and acute inflammation–related genes (IL1a, IL1b, TNF, CEBP, STAT1).”
Quote in the paperNot a substantial claim - Findingown data
If one cell type is present (20/75 cells), it is nearly always (18/20 segments) MDMs.
“If one cell type is present (20/75 cells), it’s nearly always (18/20 segments) MDMs.”
Quote in the paperSubstantial claim - Findingown data
In an equivalent sample of EAE tissues from three Ccr2rfp/rfp::Cx3cr1gfp/+ mice, only one MDM was found in contact with a node of Ranvier, despite the presence of disrupted nodes in proximity to neutrophils.
“In an equivalent sample of EAE tissues from three Ccr2rfp/rfp::Cx3cr1gfp/+ mice, only one MDM was found in contact with a node of Ranvier, despite the presence of disrupted nodes in proximity to neutrophils.”
Quote in the paperSubstantial claim - Findingown data
In one instance, a neutrophil abstracting myelin from the myelin internode was detected despite a nearby disrupted node in tissues from a Ccr2rfp/rfp::Cx3cr1gfp/+ mouse.
“In one instance, we detected a neutrophil abstracting myelin from the myelin internode (Fig. 5, left and right) despite a nearby disrupted node (Fig. 5, left) in tissues from a Ccr2rfp/rfp::Cx3cr1gfp/+ mouse.”
Quote in the paperNot a substantial claim - Findingown data
Several 3D shape parameters discriminated between MDMs and MiDMs.
“Several 3D shape parameters also discriminated between MDMs and MiDMs (Fig. 1 D).”
Quote in the paperSubstantial claim - Findingown data
There was no evidence for neutrophil recognition of disrupted nodes of Ranvier.
“Importantly, there was no evidence for neutrophil recognition of disrupted nodes of Ranvier.”
Quote in the paperSubstantial claim - Findingown data
MDM-enriched genes were sharply up-regulated from naive monocytes to onset and peak-stage MDMs, descending toward naive levels during recovery.
“MDM-enriched genes were sharply up-regulated from naive monocytes to onset and peak-stage MDMs (Fig. 6 B), descending toward naive levels during recovery (Fig. 6 B).”
Quote in the paperSubstantial claim - Findingown data
EAE onset tissues of Ccr2rfp/rfp::Cx3cr1gfp/+ mice were characterized by nodal pathology often without cellular infiltrates.
“By distinct contrast, EAE onset tissues of Ccr2rfp/rfp::Cx3cr1gfp/+ mice were characterized by nodal pathology often without cellular infiltrates (Fig. 5 D).”
Quote in the paperSubstantial claim - Findingown data
Where only one myeloid cell type was present (20/75; 27%), nearly all axoglial units made contacts to MDMs.
“Where only one myeloid cell type was present (20/75; 27%), nearly all axoglial units made contacts to MDMs (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
Remaining myelin was undergoing vesicular breakdown.
“Remaining myelin was undergoing vesicular breakdown (Fig. 3 A).”
Quote in the paperSubstantial claim - Findingown data
Most (55/75; 73%) of all segments, both intact and demyelinated, contacted both MDMs and MiDMs.
“We quantified contacts made by MDMs (n = 169) and MiDMs (n = 86) with axoglial units (n = 75; Fig. 2), and observed that most (55/75; 73%) of all segments (both intact and demyelinated) contacted both MDMs and MiDMs (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
An MDM apposed to a node of Ranvier and actively phagocytizing myelin was identified.
“Additionally we identified an MDM apposed to a node of Ranvier and actively phagocytizing myelin (Fig. 4 C).”
Quote in the paperSubstantial claim - Findingown data
MDMs have close relationship with nodes of Ranvier (7 MDMs /75 axoglial units).
“MDMs have close relationship with nodes of Ranvier (7 MDMs /75 axoglial units).”
Quote in the paperNot a substantial claim - Findingown data
Of the MDMs found in sole contact with axoglial units, virtually all (>90%) MDMs contained myelin when found in sole contact with a demyelinated axon.
“Of the MDMs found in sole contact with axoglial units, virtually all (>90%) MDMs contained myelin when found in sole contact with a demyelinated axon (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
In SBF-SEM data, only MDMs seemed to be implicated in active damage to myelin.
“In our SBF-SEM data, only MDMs seemed to be implicated in active damage to myelin.”
Quote in the paperSubstantial claim - Findingown data
The myelin peeled away from the axon remained in continuity with a large myelin inclusion inside the MDMs.
“The myelin peeled away from the axon remained in continuity with a large myelin inclusion inside the MDMs (Fig. 3 A).”
Quote in the paperSubstantial claim - Findingown data
Reconstruction of one representative image stack shows MDMs with large intracellular myelin inclusions tightly encircling a partially demyelinated axon.
“Reconstruction of one representative image stack shows MDMs with large intracellular myelin inclusions tightly encircling a partially demyelinated axon (Fig. 3 A).”
Quote in the paperSubstantial claim - Findingown data
None of the five gene groups showed coordinate regulation patterns in MDMs, as were observed in MiDMs.
“None of the gene groups showed coordinate regulation patterns in MDMs, as were observed in MiDMs (Fig. 6 H).”
Quote in the paperSubstantial claim - Findingown data
k-means clustering discriminated five distinct patterns of MiDM gene expression during the course of EAE.
“We used k-means clustering to discriminate five distinct patterns of MiDM gene expression during the course of EAE (Fig. 6, E and F).”
Quote in the paperSubstantial claim - Findingown data
Only 18/48 (37.5%) of MiDM-enriched genes encoded effector functions.
“In contrast, only 18/48 (37.5%) of MiDM-enriched genes encoded effector functions (Fig. 6 D, Table S1, purple genes).”
Quote in the paperSubstantial claim - Findingown data
MiDM expansion began at peak.
“MiDM expansion began at peak (Fig. 1 B).”
Quote in the paperSubstantial claim - Findingown data
In three distinct tissues from individual Ccr2rfp/+::Cx3cr1gfp/+ mice with EAE preonset, five MDMs attached to disrupted nodes of Ranvier were found.
“In three distinct tissues from individual Ccr2rfp/+::Cx3cr1gfp/+ mice with EAE preonset, we found five MDMs attached to disrupted nodes of Ranvier.”
Quote in the paperSubstantial claim - Findingown data
2-3 MDMs attached to each of the 18/20 (90%) axoglial units where only MDMs were present.
“We found 2–3 MDMs attached to each of the 18/20 (90%) axoglial units where only MDMs were present (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
Blue group genes up-regulated at recovery included heterogeneous cytokines (IFN-α, IFN-β, TGFB3, IL2, IL3, IL4, IL12α, IL12β, PDGFA, CSF2, and CXCL2).
“Blue group genes up-regulated at recovery included heterogeneous cytokines (IFN-α, IFN-β, TGFB3, IL2, IL3, IL4, IL12α, IL12β, PDGFA, CSF2, and CXCL2).”
Quote in the paperNot a substantial claim - Findingown data
More than half of all analyzed MDM and MiDM cells (n = 255 total) contained myelin debris, regardless of whether axon segments were intact or demyelinated.
“More than half of all analyzed MDM and MiDM cells (n = 255 total) contained myelin debris, regardless of whether axon segments were intact or demyelinated (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
7/75 (9%) of axoglial units demonstrated MDMs attached to nodes of Ranvier.
“Unexpectedly, 7/75 (9%) of axoglial units demonstrated MDMs attached to nodes of Ranvier.”
Quote in the paperSubstantial claim - Findingown data
A subset of MDM-enriched genes were dynamically regulated in monocytes and MDMs but not in microglia.
“Conversely, a subset of MDM-enriched genes were dynamically regulated in monocytes and MDMs but not in microglia (Fig. 6, A and B).”
Quote in the paperSubstantial claim - Findingown data
Equivalent magnitude of weight loss in Ccr2rfp/+::Cx3cr1gfp/+ and Ccr2rfp/rfp::Cx3cr1gfp/+ mice at preonset and onset stages of EAE showed that CCR2 deficiency did not affect systemic inflammation in this model.
“We observed equivalent magnitude of weight loss in Ccr2rfp/+::Cx3cr1gfp/+ and Ccr2rfp/rfp::Cx3cr1gfp/+ mice at preonset and onset stages of EAE, showing that CCR2 deficiency did not affect systemic inflammation in this model (Fig. 5 A).”
Quote in the paperSubstantial claim - Findingown data
Demyelination was significantly reduced at EAE onset in CCR2-deficient mice.
“Demyelination was significantly reduced at EAE onset in CCR2-deficient mice (Fig. 5 F), indicating the importance of MDM recognition of disrupted nodes for efficient inflammatory demyelination.”
Quote in the paperSubstantial claim - Findingown data
MDMs were more likely to express effector functions, including secreted factors and surface molecules (18/28; 64.3% of MDM-enriched genes encoded effector functions).
“Comparing MDM-enriched genes with MiDM-enriched genes showed that MDMs were more likely to express effector functions, including secreted factors and surface molecules (18/28; 64.3% of MDM-enriched genes encoded effector functions; Fig. 6 C; and Table S1, purple genes).”
Quote in the paperSubstantial claim - Findingown data
MDMs, but not MiDMs, frequently contained osmiophilic granules and microvilli.
“MDMs, but not MiDMs, frequently contained osmiophilic granules and microvilli (unpublished data).”
Quote in the paperNot a substantial claim - Findingown data
There were unequal numbers of MiDMs and MDMs before and after disease onset.
“Therefore, there were unequal numbers of MiDMs/MDMs before and after disease onset (Fig. 1 B).”
Quote in the paperSubstantial claim - Findingown data
MDMs and MiDMs can be distinguished by cell volume and primary processes.
“MDMs and MiDMs can be distinguished by cell volume and primary processes.”
Quote in the paperSubstantial claim - Findingown data
Most (55/75; 73%) axoglial units are contacted in limited fashion by MDMs and MiDMs.
“Most (55/75; 73%) axoglial units are contacted in limited fashion by MDMs and MiDMs.”
Quote in the paperNot a substantial claim - Findingreasoning
Using criteria detected in confocal analysis, it is possible to distinguish MDMs and MiDMs in SBF-SEM images.
“Using criteria detected in the previous step, it is possible to distinguish MDMs and MiDMs in SBF-SEM images.”
Quote in the paperSubstantial claim - Findingown data
An intratubal MDM with myelin debris interposed between compact myelin and axolemma near a node of Ranvier was detected.
“Further, we detected an intratubal (Stoll et al., 1989) MDMs with myelin debris interposed between compact myelin and axolemma near a node of Ranvier (Fig. 4 B).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Stoll et al., 1989 source
- Findingown data
MDMs had shorter, thicker mitochondria than MiDMs.
“MDMs had shorter, thicker mitochondria than MiDMs (unpublished data).”
Quote in the paperNot a substantial claim - Findingown data
No MiDMs contacted nodes of Ranvier.
“No MiDMs contacted nodes of Ranvier.”
Quote in the paperNot a substantial claim - Findingown data
MDMs and MiDMs show characteristic ultrastructural differences regarding their mitochondria, nuclei, osmiophilic granules and microvilli.
“MDMs and MiDMs show characteristic ultrastructural differences regarding their mitochondria, nuclei, osmiophilic granules and microvilli.”
Quote in the paperNot a substantial claim - Findingown data
MDMs frequently exhibited morphological characteristics suggesting an involvement in active demyelination.
“MDMs frequently exhibited morphological characteristics suggesting an involvement in active demyelination.”
Quote in the paperSubstantial claim - Findingown data
A subset of genes were expressed in microglia and highly regulated in MiDMs during EAE, but not expressed at all in monocytes or MDMs.
“We noted a subset of genes that were expressed in microglia and highly regulated in MiDMs during EAE, but not expressed at all in monocytes or MDMs (Fig. 6, A and B).”
Quote in the paperSubstantial claim - Findingown data
One representative monocyte surrounded a node of Ranvier with two microvilli interposed between myelin and axolemma near the paranode complex.
“One representative monocyte surrounded a node of Ranvier with two microvilli interposed between myelin and axolemma near the paranode complex (Fig. 4 A).”
Quote in the paperNot a substantial claim - Findingown data
A substantial minority of genes both for MDMs and MiDMs showed some dissonant time points, at which a previously down-regulated gene might show up-regulation.
“However, a substantial minority of genes both for MDMs and MiDMs showed some dissonant time points, at which a previously down-regulated gene might show up-regulation (unpublished data).”
Quote in the paperNot a substantial claim - Findingown data
MDMs showed remarkably invasive behavior, including extension of microvilli or localization of cell soma between axolemma and myelin sheath.
“showed remarkably invasive behavior, including extension of microvilli (Fig. 4 A) or localization of cell soma (Fig. 4 B) between axolemma and myelin sheath”
Quote in the paperSubstantial claim - Findingown data
The authors found strikingly divergent relationships of MDMs and MiDMs to axoglial units, by quantitative and qualitative ultrastructural analysis.
“Instead, we found strikingly divergent relationships of MDMs and MiDMs to axoglial units, by quantitative and qualitative ultrastructural analysis.”
Quote in the paperSubstantial claim - Findingown data
Expression profiles showed consonant changes for the vast majority of genes analyzed: if a gene was up-regulated at any time point, then its expression level showed an increase at other time points as well.
“These expression profiles showed consonant changes for the vast majority of genes analyzed: if a gene was up-regulated at any time point, then its expression level showed an increase at other time points as well.”
Quote in the paperSubstantial claim - Findingown data
The extent of gene up-regulation in MDMs exceeded that seen in MiDMs.
“Additionally, the extent of gene up-regulation in MDMs exceeded that seen in MiDMs.”
Quote in the paperSubstantial claim - Findingown data
In the Ingenuity IPA database, the terms cell movement, chemoattraction, and migration indicated production of chemokines such as CCL2, CCL3, CCL4, CCL5, and CCL7, which are up-regulated at onset and further increased at peak.
“In the Ingenuity IPA database, the terms cell movement, chemoattraction, and migration indicated production of chemokines such as CCL2, CCL3, CCL4, CCL5, and CCL7, which are up-regulated at onset and further increased at peak (Fig. 6, E and F, green group and genes).”
Quote in the paperNot a substantial claim - Findingown data
No functions were reported to be down-regulated in MDMs at EAE onset as compared with naive monocytes.
“No functions were reported to be down-regulated in MDMs at EAE onset as compared with naive monocytes.”
Quote in the paperNot a substantial claim - Findingown data
MDMs were unexpectedly observed at nodes of Ranvier in 9% of axoglial units.
“MDMs were unexpectedly observed at nodes of Ranvier in 9% of axoglial units”
Quote in the paperSubstantial claim - Findingown data
MDMs showed up-regulation of functions associated to macrophages, including phagocytosis, calcium signaling, production of prostanoids, adhesion, autophagy, and cell clearance.
“MDMs showed up-regulation of functions associated to macrophages, including phagocytosis, calcium signaling, production of prostanoids, adhesion, autophagy, and cell clearance (Fig. 7 B).”
Quote in the paperSubstantial claim - Findingown data
Grouping of regulated genes into functional categories demonstrated a remarkable down-regulation of microglial metabolism at the nuclear, cytoplasmic and cytoskeletal levels.
“Grouping of regulated genes into functional categories demonstrated a remarkable down-regulation of microglial metabolism at the nuclear, cytoplasmic and cytoskeletal levels.”
Quote in the paperNot a substantial claim - Findingown data
Naive and recovery patterns were similar for both cell types.
“Naive and recovery patterns were similar for both cell types.”
Quote in the paperNot a substantial claim - Findingown data
Neutrophils in inflamed CNS of Ccr2rfp/rfp::Cx3cr1gfp/+ mice did not recognize disrupted nodes.
“neutrophils in inflamed CNS of Ccr2rfp/rfp::Cx3cr1gfp/+ mice did not recognize disrupted nodes”
Quote in the paperSubstantial claim - Findingown data
Both MiDMs and MDMs demonstrated this pattern of gene-expression kinetics.
“Both MiDMs (Fig. 8 B) and MDMs (Fig. 8 D) demonstrated this pattern of gene-expression kinetics.”
Quote in the paperSubstantial claim - Findingown data
MiDMs showed highly significant up-regulation of functions associated with cell movement, chemoattraction, and migration.
“MiDMs showed highly significant up-regulation of functions associated with cell movement, chemoattraction, and migration (Fig. 7 B).”
Quote in the paperSubstantial claim - Findingown data
Cell motility pathways were clearly different in MiDMs and MDMs.
“Cell motility pathways were clearly different in MiDMs and MDMs (unpublished data).”
Quote in the paperNot a substantial claim - Findingown data
MDMs up-regulated a large suite of inflammation-associated genes at EAE onset, with subsequent regression to the expression phenotype of circulating monocytes.
“MDMs up-regulated a large suite of inflammation-associated genes at EAE onset, with subsequent regression to the expression phenotype of circulating monocytes.”
Quote in the paperSubstantial claim - Findingown data
The authors noted differential nuclear morphology, mitochondrial shape, and osmiophilic granule content between MDMs and MiDMs.
“We also noted differential nuclear morphology, mitochondrial shape, and osmiophilic granule content between MDMs and MiDMs.”
Quote in the paperNot a substantial claim - Findingown data
GAPDH was up-regulated in MiDMs at onset.
“GAPDH was up-regulated in MiDMs at onset.”
Quote in the paperNot a substantial claim - Findingown data
Gene expression profiling across the time course of EAE yielded five patterns as analyzed by k-means clustering.
“Gene expression profiling across the time course of EAE yielded intriguing kinetics as analyzed by k-means clustering. Five patterns were observed.”
Quote in the paperNot a substantial claim - Findingown data
The authors characterized a molecular signature for resident microglia at EAE onset.
“we characterized a molecular signature for resident microglia at EAE onset”
Quote in the paperSubstantial claim - Findingown data
Both HIF-1α and TNF pathways were also differentially regulated in MiDMs and MDMs.
“Both HIF-1α (Fig. 9 A) and TNF pathways (not depicted) were also differentially regulated in MiDMs and MDMs.”
Quote in the paperSubstantial claim - Findingown data
MiDM metabolism was severely down-regulated.
“MiDM metabolism was severely down-regulated”
Quote in the paperSubstantial claim - Findingown data
MiDMs exhibited a repressed metabolic and activation phenotype by comparison to naive microglia, including proliferation, RNA metabolism, cytoskeletal organization, microtubule dynamics, extension of processes, phagocytosis and generation of reactive oxygen species.
“In other respects, MiDMs exhibited a repressed metabolic and activation phenotype by comparison to naive microglia (Fig. 7 B) including proliferation, RNA metabolism, cytoskeletal organization, microtubule dynamics, extension of processes, phagocytosis and generation of reactive oxygen species.”
Quote in the paperSubstantial claim - Findingown data
Type I IFN pathway was regulated virtually identically in MiDMs and MDMs.
“By contrast, type I IFN pathway (Fig. 9 B) was regulated virtually identically in MiDMs and MDMs.”
Quote in the paperSubstantial claim - Findingown data
The presence of myelin debris at the peak of EAE did not discriminate MDMs from MiDMs.
“the presence of myelin debris at the peak of EAE did not discriminate MDMs from MiDMs”
Quote in the paperSubstantial claim - Findingown data
At disease onset, microglia showed drastic down-regulation of the expression profile observed in cells from healthy brain.
“At disease onset, microglia showed drastic down-regulation of the expression profile observed in cells from healthy brain.”
Quote in the paperSubstantial claim - Premisecitation
To date, no research techniques have permitted distinction between monocytes and microglia in CNS tissue without irradiation chimerism or parabiosis, techniques that confound interpretation or impose practical limitations.
“To date, no research techniques have permitted distinction between monocytes and microglia in CNS tissue without irradiation chimerism or parabiosis, techniques that confound interpretation or impose practical limitations (Ajami et al., 2007, 2011; Ransohoff, 2007).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Ajami et al., 2007, 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Ransohoff, 2007 source
- Interpretationown data
Phagocytic microglia appear relatively inert at disease onset.
“In contrast, phagocytic microglia appear relatively inert at disease onset.”
Quote in the paperSubstantial claim - Interpretationown data
Monocyte-derived macrophages initiate demyelination, often at nodes of Ranvier.
“Here we provide evidence that MDMs initiate demyelination, often at nodes of Ranvier.”
- Also stated in: § MDMs initiated demyelination at EAE onset · plain
“MDMs initiated demyelination at EAE onset”
Quote in the paperSubstantial claim - Also stated in: § MDMs initiated demyelination at EAE onset · plain
- Interpretationreasoning
Differential functions of monocyte-derived macrophages and microglia-derived macrophages are relevant for human demyelinating disease.
“Therefore, differential functions of MDMs and MiDMs are relevant for human demyelinating disease.”
Quote in the paperSubstantial claim - Interpretationown data
In each case, the contact between MDMs and node appeared to be pathogenic.
“In each case, the contact between MDMs and node appeared to be pathogenic.”
Quote in the paperSubstantial claim - Interpretationreasoning
As nodal pathology was equivalent in Ccr2rfp/rfp::Cx3cr1gfp/+ and Ccr2rfp/+::Cx3cr1gfp/+ mice at the preonset stage of EAE, inflammatory nodal disruption could be reversible if MDMs were prevented from initiating demyelination at those sites.
“Furthermore, as nodal pathology was equivalent in Ccr2rfp/rfp::Cx3cr1gfp/+ (Fig. 5 D) and Ccr2rfp/+::Cx3cr1gfp/+ mice at the preonset stage of EAE, the results suggested that inflammatory nodal disruption could be reversible if MDMs were prevented from initiating demyelination at those sites.”
Quote in the paperSubstantial claim - Interpretationown data
These observations suggested that MDMs initiated demyelination at the onset of EAE.
“These observations suggested that MDMs initiated demyelination at the onset of EAE.”
Quote in the paperSubstantial claim - Interpretationown data
MDM recognition of disrupted nodes is important for efficient inflammatory demyelination.
“Demyelination was significantly reduced at EAE onset in CCR2-deficient mice (Fig. 5 F), indicating the importance of MDM recognition of disrupted nodes for efficient inflammatory demyelination.”
Quote in the paperSubstantial claim - Interpretationown data
MiDMs and MDMs exhibited markedly distinct expression profiles during EAE.
“These observations indicated that MiDMs and MDMs exhibited markedly distinct expression profiles during EAE.”
Quote in the paperSubstantial claim - Premisecitation
Cell growth-related genes expressed at this time point correlated to reported patterns of microglial proliferation during EAE.
“Cell growth–related genes expressed at this time point correlated to reported patterns of microglial proliferation during EAE (Ajami et al., 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ajami et al., 2011 source
- Interpretationown data
This observation suggested that initial MDM-axoglial contacts might occur at nodes of Ranvier.
“This observation suggested that initial MDM–axoglial contacts might occur at nodes of Ranvier.”
Quote in the paperNot a substantial claim - Interpretationown data
Comparison of Ccr2rfp/rfp::Cx3cr1gfp/+ and Ccr2rfp/+::Cx3cr1gfp/+ mice at and before EAE onset emphasized the importance of MDMs for this mechanism of demyelination.
“Comparison of Ccr2rfp/rfp::Cx3cr1gfp/+ and Ccr2rfp/+::Cx3cr1gfp/+ mice at and before EAE onset emphasized the importance of MDMs for this mechanism of demyelination.”
Quote in the paperSubstantial claim - Interpretationown data
This pathway analysis corresponded well to effector properties displayed by MDMs in the SBF-SEM analysis.
“This pathway analysis corresponded well to effector properties displayed by MDMs in our SBF-SEM analysis (Figs. 2–4).”
Quote in the paperNot a substantial claim - Study design and conductnone given
In this study, the authors developed a novel strategy to discriminate MDMs from MiDMs.
“In this study, we developed a novel strategy to discriminate MDMs from MiDMs.”
Quote in the paperSubstantial claim - Interpretationcitation
The authors' detection of MDMs at nodes of Ranvier is consistent with recent reports of nodal pathology in clinical demyelinated tissues.
“our detection of MDMs at nodes of Ranvier is consistent with recent reports of nodal pathology in clinical demyelinated tissues (Fu et al., 2011; Desmazières et al., 2012)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Fu et al., 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Desmazières et al., 2012 source
- Interpretationown data
Expression profiles of MDMs reflected the activated phagocytic phenotype observed through SBF-SEM.
“expression profiles of MDMs reflected the activated phagocytic phenotype observed through SBF-SEM”
Quote in the paperSubstantial claim - Study design and conductnone given
Blood monocytes and resident microglia were exposed to the same inflammatory environment.
“Blood monocytes and resident microglia were exposed to the same inflammatory environment.”
Quote in the paperSubstantial claim- Rests on an assumption: The EAE disease model exposes both recruited monocytes and resident microglia to the same intensely inflammatory environment.
- Interpretationown data
MiDMs and MDMs have disparate responses to the inflammatory CNS microenvironment of EAE, despite their being present in close proximity.
“This observation underscored disparate responses of MiDMs and MDMs to the inflammatory CNS microenvironment of EAE, despite their being present in close proximity (Fig. 1 A).”
Quote in the paperSubstantial claim - Study design and conductcitation
At the onset of EAE, the authors are able to make an unequivocal distinction between resident microglia (CX3CR1gfp) and infiltrating monocytes (CCR2rfp).
“At the onset of EAE, the time point at which our imaging studies were focused, we are able to make an unequivocal distinction between resident microglia (CX3CR1gfp) and infiltrating monocytes (CCR2rfp).”
Quote in the paperSubstantial claim - Premisecitation
Gene expression by morphologically identical microglia can differ drastically contingent on context.
“gene expression by morphologically identical microglia can differ drastically contingent on context (Perry et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Perry et al., 2007 source
- Study design and conductown data
The observed frequency of MDM-nodal interaction represents a minimum estimate as MDMs found at heminodes adjacent to a demyelinated segment were not scored.
“Our observed frequency of MDM–nodal interaction represents a minimum estimate as MDMs found at heminodes adjacent to a demyelinated segment (Fig. 3 B) were not scored.”
Quote in the paperNot a substantial claim - Interpretationown data
MDMs initiate demyelination at EAE onset.
“we showed that MDMs initiate demyelination at EAE onset”
Quote in the paperSubstantial claim - Study design and conductnone given
Selection of the EAE disease model ensured that both recruited monocytes and resident microglia were exposed to the same intensely inflammatory environment to increase the likelihood that ambient conditions could activate these two myeloid cell types toward a convergent inflammatory phenotype.
“Selection of the EAE disease model ensured that both recruited monocytes and resident microglia were exposed to the same intensely inflammatory environment to increase the likelihood that ambient conditions could activate these two myeloid cell types toward a convergent inflammatory phenotype.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Exposure of monocytes and microglia to the same intensely inflammatory environment increases the likelihood that they adopt a convergent inflammatory phenotype.
- Interpretationown data
HIF-1α and TNF signaling may partly drive pathogenic properties of MDMs.
“Collectively, these data suggest that HIF-1α and TNF signaling may partly drive pathogenic properties of MDMs.”
Quote in the paperSubstantial claim - Interpretationown data
The authors' findings carry biological and medical significance by demonstrating and characterizing differential responses of infiltrating monocytes and resident microglia in a relevant disease model at a prespecified time point, at which point pathogenic events are taking place.
“Our findings carry biological and medical significance by demonstrating and characterizing differential responses of infiltrating monocytes and resident microglia in a relevant disease model at a prespecified time point, at which point pathogenic events are taking place.”
Quote in the paperSubstantial claim
- May combine two claims. 39
- Classified as probably not a substantial claim. 16
May combine two claims.
PremisecitationIn double-heterozygous Ccr2rfp::Cx3cr1gfp mice with EAE, GFP is expressed by CD45dim/Ly6C− microglia, whereas RFP is restricted to CD45high/Ly6C+ monocytes.
“When F4/80+ macrophages were isolated from CNS and analyzed by flow cytometry using cells from double-heterozygous Ccr2rfp::Cx3cr1gfp mice with EAE, GFP was expressed by CD45dim/Ly6C− microglia, whereas RFP was restricted to CD45high/Ly6C+ monocytes (Saederup et al., 2010; Mizutani et al., 2012).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Saederup et al., 2010 source
The Results section (Infiltration by CD115+ monocytes; page not supplied) reports GFP-high, RFP-negative CD45-low microglia at peak EAE, supporting the microglial part of the claim. But the Discussion reports RFP-low Ly6C-low cells in the diseased CNS, and the Results (Three color imaging with a myeloid marker) identifies RFP-positive cells likely to be Ly6C-low monocytes or T cells. RFP is therefore not restricted to Ly6C-positive monocytes as claimed. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Mizutani et al., 2012 source
The Results section (Fig. 6A,B; page not provided) reports GFP-positive microglia and RFP in CD45-high infiltrating leukocytes, with no RFP signal in CD45-low microglia, in double-reporter mice with EAE. It does not report isolating F4/80-positive macrophages or directly establish the claimed Ly6C-negative and Ly6C-positive gates; its RFP finding is stated for CD45-high leukocytes rather than exclusively for Ly6C-positive monocytes. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
FindingcitationThese genes included a large spectrum of intracellular signaling components from the MAP-kinase pathways, as well as TGFβ and receptor, both of which are implicated in the naïve microglial phenotype.
“These genes included a large spectrum of intracellular signaling components from the MAP-kinase pathways, as well as TGFβ and receptor, both of which are implicated in the naïve microglial phenotype (Butovsky et al., 2014).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Butovsky et al., 2014 source
The Results section identifies Tgfbr1 as a microglia-specific gene and reports that TGF-β is important for microglial development and maintenance. The passages do not establish that a broad spectrum of MAP-kinase signaling components is implicated in the naïve microglial phenotype; searches for MAP-kinase and MAPK did not find that point. Page numbers were unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataAt EAE onset, MiDMs predominantly suppressed the distinctive gene expression pattern which correlates to their unique phenotype, reflected by the observation that MiDMs down-regulated far more genes than were up-regulated.
“At EAE onset when SBF-SEM analyses were performed, MiDMs predominantly suppressed the distinctive gene expression pattern which correlates to their unique phenotype (Chiu et al., 2013), reflected by the observation that MiDMs down-regulated far more genes than were up-regulated (Table S1).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Chiu et al., 2013 source
The Results section on microglia-specific marker genes identifies a distinctive expression pattern that separates microglia from peripheral macrophages and monocytes. Chiu et al. studied an ALS mouse model, however, and do not establish that MiDMs suppress that pattern at EAE onset; the citing sentence attributes the up- versus down-regulated gene count to its own Table S1. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGAPDH is found in complexes that limit the translation of inflammatory gene transcripts in activated mouse macrophages.
“GAPDH is found in complexes that limit the translation of inflammatory gene transcripts in activated mouse macrophages (Mukhopadhyay et al., 2009; Arif et al., 2012).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Mukhopadhyay et al., 2009 source
The “Elucidation of the heterotetrameric GAIT complex” section identifies GAPDH as part of the functional GAIT complex, and the Abstract says that complex suppresses translation of inflammatory mRNAs in myeloid cells. The copy describes IFN-γ-treated human monocytes and monocytic cells, but does not establish this finding specifically in activated mouse macrophages. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites Arif et al., 2012 source
May combine two claims.
InterpretationcitationThe authors' conclusions should not be generalized beyond the present disease paradigm: in other models, such as spinal cord contusion, the inflammatory infiltrate includes Ly6Clow/CX3CR1gfp monocytes, which are highly pathogenic.
“our conclusions should not be generalized beyond the present disease paradigm: in other models, such as spinal cord contusion, the inflammatory infiltrate includes Ly6Clow/CX3CR1gfp monocytes, which are highly pathogenic (Donnelly et al., 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Donnelly et al., 2011 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationActivated myeloid cells are the proximate effectors of a bewildering array of acute and chronic disorders.
“Activated myeloid cells are the proximate effectors of a bewildering array of acute and chronic disorders (Wynn et al., 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Wynn et al., 2013 source
The ‘Macrophages in disease’ section describes inflammatory macrophages causing tissue damage after injury and contributing to chronic inflammatory and autoimmune disease. ‘Macrophages in inflammatory disease’ also identifies roles in several chronic conditions. The paper does not establish the broader claim that activated myeloid cells generally are the proximate effectors of a wide array of both acute and chronic disorders; it also describes protective macrophage roles. Page numbers were not available in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTotal mitochondrial numbers and volumes were equal in MDMs and MiDMs.
“Total mitochondrial numbers and volumes were equal in MDMs and MiDMs (unpublished data).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn all, 49 MDMs interacting with axoglial units in absence of nearby MiDMs, 2-3 MDMs were attached to each (n = 18) axoglial unit.
“In all, 49 MDMs interacting with axoglial units in absence of nearby MiDMs, 2-3 MDMs were attached to each (n = 18) axoglial unit.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMDMs had bilobulated or irregular nuclei, whereas MiDMs had round nuclei.
“MDMs had bilobulated or irregular nuclei, whereas MiDMs had round nuclei (unpublished data).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data3D reconstructions showed four representative MDMs at axoglial units: one carrying out active demyelination, three at nodes of Ranvier.
“3D reconstructions showed four representative MDMs at axoglial units: show one carrying out active demyelination, three at nodes of Ranvier.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA nearby MiDM encompassed a large fragment of myelin debris and contacted the nearby MDMs, but made minimal connection to the axoglial unit.
“In contrast, a nearby MiDM encompassed a large fragment of myelin debris (Fig. 3 B) and contacted the nearby MDMs (Fig. 3 B), but made minimal connection to the axoglial unit (Fig. 3 B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt recovery, MiDMs were found near preonset numbers as MDM frequency continued to decline.
“At recovery, MiDMs were found near preonset numbers as MDM frequency continued to decline, which is compatible with previous studies (Ajami et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ajami et al., 2011 source
May combine two claims.
Findingown dataThere was a moderate delay in disease onset and slight reduction in EAE onset severity in Ccr2rfp/rfp::Cx3cr1gfp/+ mice.
“There was a moderate delay in disease onset (Fig. 5 B) and slight reduction in EAE onset severity (Fig. 5 A) in Ccr2rfp/rfp::Cx3cr1gfp/+ mice.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenRed group genes involved several surface molecules.
“Red group genes involved several surface molecules.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data8/29 intact and 10/46 demyelinated axoglial units were contacted solely by MDMs.
“In particular, 8/29 intact and 10/46 demyelinated axoglial units were contacted solely by MDMs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere was scant overlap of several values between MDMs and MiDMs, and entirely nonoverlapping distributions for cell volume and primary processes.
“We observed scant overlap of several values between MDMs and MiDMs (Fig. 1 D), and entirely nonoverlapping distributions for cell volume and primary processes (Fig. 1 E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth yellow group and golden group genes were strongly expressed in naive microglia, reduced drastically at onset, and either returned to preEAE levels during recovery (yellow) or failed to do so (golden).
“Both yellow group and golden group genes were strongly expressed in naive microglia, reduced drastically at onset, and either returned to preEAE levels during recovery (yellow) or failed to do so (golden).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMiDMs exhibited much larger size than MDMs along with multiple primary processes, which were sparse in MDMs.
“Quantification in 3D reconstructions from 0.2-µm confocal z-stack images showed that MiDMs exhibited much larger size than MDMs along with multiple primary processes, which were sparse in MDMs (Fig. 1 D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMicroglia and MiDMs clustered together during unsupervised hierarchical clustering, as did monocytes and MDMs.
“Microglia and MiDMs clustered together during unsupervised hierarchical clustering, as did monocytes and MDMs (Fig. 6, A and B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRed, blue and green groups increased in MiDMs at onset, peak, and recovery, respectively.
“The red, blue and green groups increased in MiDMs at onset, peak, and recovery, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAt this node, paranode loops were disrupted and surrounded by MDM cytosol, indicating likely involvement in damaging myelin near the node.
“At this node, paranode loops were disrupted and surrounded by MDM cytosol (Fig. 4 C), indicating likely involvement in damaging myelin near the node.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOne representative MDM from Ccr2rfp/+::Cx3cr1gfp/+ tissue having concave nucleus had multiple intracellular myelin inclusions, one of which was physically connected to a myelin sheath at a paranode, indicating active ongoing demyelination at a node of Ranvier.
“One representative MDM from Ccr2rfp/+::Cx3cr1gfp/+ tissue having concave nucleus (Fig. 5 C, left) had multiple intracellular myelin inclusions, one of which (Fig. 5 C, left middle) was physically connected to a myelin sheath (Fig. 5 C, right middle) at a paranode (Fig. 5 C, right), indicating active ongoing demyelination at a node of Ranvier.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMiDM-enriched genes were strongly expressed in naive cells, almost uniformly silenced at onset, and began a return toward naive levels at peak and recovery.
“In contrast, MiDM-enriched genes were strongly expressed in naive cells, almost uniformly silenced at onset, and began a return toward naive levels at peak and recovery (Fig. 6 B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe axoglial unit appeared otherwise healthy and no myelin debris was found in the MDM cytosol.
“The axoglial unit appeared otherwise healthy and no myelin debris was found in the MDM cytosol.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRed MDMs exhibited elongated or spindle shape, whereas green MiDMs showed a process-bearing morphology at EAE onset.
“Immunofluorescence staining for RFP and GFP in spinal cord at EAE onset showed that red MDMs exhibited elongated or spindle shape, whereas green MiDMs showed a process-bearing morphology (Fig. 1 C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMDMs were the overwhelmingly dominant cells found in isolation attached to axoglial units and demonstrated destructive interactions with myelinated axons in 3D reconstructions.
“MDMs were the overwhelmingly dominant cells found in isolation attached to axoglial units and demonstrated destructive interactions with myelinated axons in 3D reconstructions”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn virtually every case, these dissonant compensatory changes took place during recovery and almost always showed an increase in a gene that had been down-regulated during onset and peak.
“In virtually every case (Fig. 8, A–D), these dissonant compensatory changes took place during recovery and almost always showed an increase in a gene that had been down-regulated during onset and peak.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn contrast, MDMs up-regulated far more genes than did MiDMs and up-regulated more transcripts than were down-regulated.
“In contrast, MDMs up-regulated far more genes than did MiDMs and up-regulated more transcripts than were down-regulated.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCore elements such as RhoA were regulated divergently and associated signaling components were predicted to be enhanced in MDMs but depressed in MiDMs, consistent with phenotypic characterization using SBF-SEM.
“Core elements such as RhoA (Xu et al., 2009) were regulated divergently and associated signaling components were predicted to be enhanced in MDMs but depressed in MiDMs, consistent with our phenotypic characterization using SBF-SEM.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xu et al., 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataRed group genes (increased at onset) comprised the smallest number and involved several surface molecules: CCR1, CCR7, CXCR2, and CD40.
“Red group genes (increased at onset) comprised the smallest number and involved several surface molecules: CCR1, CCR7, CXCR2, and CD40.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMicroglial precursors are Myb independent, and microglia self-renew independently of bone marrow hematopoietic stem cells.
“Microglial precursors are Myb independent, and microglia self-renew independently of bone marrow HSCs (Gomez Perdiguero et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gomez Perdiguero et al., 2013 source
Classified as probably not a substantial claim.
InterpretationreasoningDistinct developmental origin and renewal mechanisms imply that monocyte-derived macrophages and microglia-derived macrophages might exert different functions in pathological processes.
“Distinct developmental origin and renewal mechanisms imply that monocyte-derived macrophages (MDMs) and microglia-derived macrophages (MiDMs) might exert different functions in pathological processes.”
Quote in the paperSubstantial claim- Rests on an assumption: Monocytes continuously differentiate throughout postnatal life from bone marrow hematopoietic stem cells, which require the transcription factor Myb.
May combine two claims.
PremisecitationIn EAE, macrophages dominate the inflammatory infiltrates and their numbers correlate to EAE severity.
“In EAE, which models inflammatory aspects of MS (Williams et al., 1994; Ransohoff, 2012), macrophages dominate the inflammatory infiltrates and their numbers correlate to EAE severity (Huitinga et al., 1990, 1993; Ajami et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Huitinga et al., 1990, 1993
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Ajami et al., 2011 source
May combine two claims.
Interpretationown dataMDMs recognized altered nodal structure and initiated demyelination at EAE onset.
“We interpreted our ultrastructural findings to indicate that MDMs recognized altered nodal structure and initiated demyelination at EAE onset.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataIn both MiDMs and MDMs, naive and recovery-stage expression profiles were more alike than were onset and peak-stage profiles, suggesting a return to homeostasis at EAE recovery.
“In both MiDMs and MDMs, naive and recovery-stage expression profiles were more alike than were onset and peak-stage profiles (Fig. 6, A and B) suggesting a return to homeostasis at EAE recovery.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Interpretationown dataThese characteristics of MDMs and MiDMs may not be universally present in other pathological circumstances but demonstrate an approach to ultrastructural distinction of myeloid cell populations in tissue sections.
“These characteristics of MDMs and MiDMs may not be universally present in other pathological circumstances but demonstrate an approach to ultrastructural distinction of myeloid cell populations in tissue sections.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe separate ontogeny of microglia and monocytes will lead, probably by epigenetic influences, to divergent responses to some but not all environmental stimuli, with phenotypic consequences according to the CNS microenvironment.
“Additionally, these data indicated that the separate ontogeny of microglia and monocytes will lead, probably by epigenetic influences, to divergent responses to some but not all environmental stimuli, with phenotypic consequences according to the CNS microenvironment.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductcitationThe dual reporter system is sufficient to accurately distinguish monocyte versus microglial cells and thus to address the general concept that monocytes and microglia can exert differential functions in a CNS disease process.
“The strength of the study is that the dual reporter system is sufficient to accurately distinguish monocyte versus microglial cells and thus to address the general concept that monocytes and microglia can exert differential functions in a CNS disease process.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe present observations extend the concept of nodal pathology and provide a cellular basis for nodal pathology at the earliest stages of demyelination.
“The present observations extend this concept and provide a cellular basis for nodal pathology at the earliest stages of demyelination.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe authors developed methods based on cell volume and process number to distinguish MDMs from MiDMs in 0.2-μm confocal optical sections, and translated this approach directly to SBF-SEM image sets at 0.2-μm intervals.
“we developed methods based on cell volume and process number (Fig. 1 E), to distinguish MDMs from MiDMs in 0.2-µm confocal optical sections, and translated this approach directly to SBF-SEM image sets at 0.2-µm intervals.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCCR7 and CD40 have been reported on activated microglia, including those observed in MS tissue sections.
“CCR7 and CD40 have been reported on activated microglia, including those observed in MS tissue sections (Kivisäkk et al., 2004; Serafini et al., 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenThe preEAE states of monocytes and microglia were extremely distinct, with monocytes being generated from a bone marrow progenitor within weeks of entry into CNS, whereas microglia originated during early embryogenesis and had inhabited a serum-free unique environment from midgestation.
“their preEAE states were extremely distinct, with monocytes being generated from a bone marrow progenitor within weeks of entry into CNS, whereas microglia originated during early embryogenesis and had inhabited a serum-free unique environment from midgestation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenBlinded observers (n = 3) scoring the nuclear morphology from SBF-SEM images included a research student, a research fellow and a neuroscientist.
“Blinded observers (n = 3) scoring the nuclear morphology from SBF-SEM images included a research student, a research fellow and a neuroscientist.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThe technical and conceptual approach taken in this study may be applicable to other tissues and disease processes.
“The technical and conceptual approach taken in this study may be applicable to other tissues and disease processes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenEach experiment incorporated samples from at least three separate immunizations.
“Each experiment incorporated samples from at least three separate immunizations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe therapeutic strategy will differ conclusively based on the specific effector properties of each cell type and the stage of disease.
“The therapeutic strategy will differ conclusively based on the specific effector properties of each cell type and the stage of disease.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataKappa test showed good pairwise agreement rates among observers (>0.8) and the data from the neuroscientist are used.
“Kappa test showed good pairwise agreement rates among observers (>0.8) and the data from the neuroscientist are used.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAnimal experiments were performed according to the protocols approved by the Institutional Animal Care and Use Committee at the Cleveland Clinic following the National Institutes of Health guidelines for animal care.
“Animal experiments were performed according to the protocols approved by the Institutional Animal Care and Use Committee at the Cleveland Clinic following the National Institutes of Health guidelines for animal care.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningIt was beyond the scope of the study to decipher the phenotypic fate of infiltrated monocytes.
“it was beyond the scope of our study to decipher the phenotypic fate of infiltrated monocytes.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningTo address how monocytes and microglia respond to a shared microenvironment, the authors focused on a single, pathogenically relevant time point: onset of EAE.
“to address how monocytes and microglia respond to a shared microenvironment, we focused on a single, pathogenically relevant time point: onset of EAE.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe authors performed 12 EAE immunizations in Ccr2rfp/+::Cx3cr1gfp/+ mice and 19 immunizations in Ccr2rfp/rfp::Cx3cr1gfp/+ mice for this project, with 8-10 mice in each immunization.
“In all, we performed 12 EAE immunizations in Ccr2rfp/+::Cx3cr1gfp/+ mice and 19 immunizations in Ccr2rfp/rfp::Cx3cr1gfp/+ mice for this project, with 8–10 mice in each immunization.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Monocytes continuously differentiate throughout postnatal life from bone marrow hematopoietic stem cells, which require the transcription factor Myb.
“whereas monocytes continuously differentiate throughout postnatal life from bone marrow hematopoietic stem cells (HSCs), which require the transcription factor Myb.”
The paper relies on this without support.
Macrophages derived from microglia and monocytes are indistinguishable at the light microscopic level both morphologically and by surface markers.
“In tissue sections, macrophages derived from these two distinct precursors are indistinguishable at the light microscopic level both morphologically and by surface markers.”
The paper relies on this without support.
There is virtually no background trafficking of monocytes in the CNS parenchyma of healthy animals.
“as there is virtually no background trafficking of monocytes in the CNS parenchyma of healthy animals.”
The authors state this as an assumption.
The cellular mechanisms by which macrophages promote disease progression are uncertain.
“However the cellular mechanisms by which macrophages promote disease progression are uncertain.”
The paper relies on this without support.
Microglia represent one instance of tissue-resident macrophages, which reside in all organs.
“Microglia represent one instance of tissue-resident macrophages, which reside in all organs.”
The authors state this as an assumption.
Exposure of monocytes and microglia to the same intensely inflammatory environment increases the likelihood that they adopt a convergent inflammatory phenotype.
“to increase the likelihood that ambient conditions could activate these two myeloid cell types toward a convergent inflammatory phenotype”
The paper relies on this without support.
The EAE disease model exposes both recruited monocytes and resident microglia to the same intensely inflammatory environment.
“Selection of the EAE disease model ensured that both recruited monocytes and resident microglia were exposed to the same intensely inflammatory environment”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Using Ccr2rfp::Cx3cr1gfp reporter mice, resident microglia appeared to be more involved in phagocytosing myelin debris and tissue repair, whereas MDMs in the immediate vicinity of axons at the nodes of Ranvier expressed a pro-inflammatory gene signature, suggesting that these cells actively participate in inflammatory myelin damage.
“Using this method, resident microglia appeared to be more involved in phagocytosing myelin debris and tissue repair, whereas MDMs in the immediate vicinity of axons at the nodes of Ranvier expressed a pro-inflammatory gene signature [355], suggesting that these cells actively participate in inflammatory myelin damage.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [355]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredIn one EAE study, macrophages were associated with demyelination, while microglia were anti-inflammatory and required for debris removal.
“In one EAE study, macrophages were associated with demyelination, while microglia were anti-inflammatory and required for debris removal (53).”
From Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection (2020) · cites this paper as [53]
The Results section ('MDMs initiated demyelination at EAE onset'; page unavailable) links monocyte-derived macrophages to active demyelination and shows a microglial-derived macrophage engulfing myelin debris. It does not establish that microglia are required for debris removal; it also reports myelin debris in both cell types. The supplied gene-expression Results passage lists inflammation-related genes up-regulated in microglia, so the description of them as anti-inflammatory is not supported. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThese results are consistent with others describing distinct functions for microglia and hematogenously derived macrophages in CNS pathologies.
“These results are consistent with others describing distinct functions for microglia and hematogenously derived macrophages in CNS pathologies (53–55).”
From Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection (2020) · cites this paper as [53]
Given the distinct genetic and transcriptomic profile of microglia and macrophages identified via high throughput sequencing technology, the two cell types likely maintain different roles in the injured CNS.
“Given the distinct genetic and transcriptomic profile of microglia and macrophages identified via high throughput sequencing technology (69–71), the two cell types likely maintain different roles in the injured central nervous system (CNS) (72–74).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [72]
At disease onset, microglia promote axonal regeneration, remyelination, clearance of inhibitory myelin debris, and release of neurotrophic factors, suggesting a beneficial role.
“However, at disease onset, microglia promote axonal regeneration, remyelination, clearance of inhibitory myelin debris, and the release of neurotrophic factors, suggesting a beneficial role67.”
From Microglia in neurodegeneration (2018) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Expression-profiling sample sizes conflict
MajorThe gene-expression methods say RNA was pooled from three mice per data point, whereas Figure 6 describes a pool of five mice at each time point.
“RNA was isolated from FACS-sorted cells mixed from three mice from six EAE inductions per data point in TRIzol Reagent (Ambion) according to manufacturer’s protocol.”
“Each row of the heat map represents an individual gene and each column an individual group from pool of 5 mice at each time point.”
Figure 5 legend names the same genotype twice for a two-genotype comparison
MinorThe Figure 5F description lists two identical Ccr2rfp/+ groups, while its sample description lists both Ccr2rfp/+ and Ccr2rfp/rfp groups.
“quantification of demyelinated area of Ccr2rfp/+::Cx3cr1gfp/+ mice and Ccr2rfp/+::Cx3cr1gfp/+ mice.”
“We studied 5 naive Ccr2rfp/+::Cx3cr1gfp/+ mice, 5 naive Ccr2rfp/rfp::Cx3cr1gfp/+ mice, 5 onset Ccr2rfp/+::Cx3cr1gfp/+ mice, and 5 onset Ccr2rfp/rfp::Cx3cr1gfp/+ mice”
Figure 7 panel cited for MDM functions is labeled MiDM
MinorThe text attributes MDM up-regulated functions to Figure 7B, but the figure legend assigns MDM functions to panel A and MiDM functions to panel B.
“MDMs showed up-regulation of functions associated to macrophages, including phagocytosis, calcium signaling, production of prostanoids, adhesion, autophagy, and cell clearance (Fig. 7 B).”
“(A) MDMs up-regulated functions, sorted by activation z-score. (B) MiDMs up-regulated (left) and down-regulated (right) functions, sorted by activation z score.”
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · see citing works
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · see citing works
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029 · see citing works
Self-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · see citing works
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,579 · see citing works
Self-citationA Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578 · see citing works
the Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972 · cited 1× · see citing works
“…analysis (Kulkarni, 2011) was performed using directly ex vivo naive microglia and splenic F4/80 + macrophages (here termed monocytes and considered similar to microglia by expression profiling; Gautier et al., 2012), as well as flow-sorted MiDMs or MDMs across the time course of an EAE attack.”
MethodSerial Block-Face Scanning Electron Microscopy to Reconstruct Three-Dimensional Tissue Nanostructure
Denk, W., & Horstmann, H. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020329 · Cited by 1,644 · see citing works
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643 · see citing works
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532 · see citing works
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · see citing works
Self-citationInfiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061 · see citing works
Systemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027 · see citing works
Chiu, I. M., Morimoto, E. T. A., Goodarzi, H., Liao, J. T., O’Keeffe, S., Phatnani, H. P., Muratet, M., Carroll, M. C., Levy, S., Tavazoie, S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.018 · Cited by 651 · see citing works
Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C.-L., Ransohoff, R. M., & Charo, I. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013693 · Cited by 599 · see citing works
Self-citationIzikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., & Luster, A. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1075 · Cited by 584 · see citing works
Self-citationStoll, G., Griffin, J. W., Li, C. Y., & Trapp, B. D. (1989) · Journal of Neurocytology · doi:10.1007/bf01187086 · Cited by 556 · see citing works
Monocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 521 · see citing works
Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.899 · Cited by 511 · see citing works
Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., & Dijkstra, C. D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1025 · Cited by 506 · see citing works
Clearing the Dead: Apoptotic Cell Sensing, Recognition, Engulfment, and Digestion
Hochreiter-Hufford, A., & Ravichandran, K. S. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008748 · Cited by 503 · see citing works
Animal models of multiple sclerosis: the good, the bad and the bottom line
Ransohoff, R. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3168 · Cited by 379 · see citing works
Self-citationWei, S., Nandi, S., Chitu, V., Yeung, Y.-G., Yu, W., Huang, M., Williams, L. T., Lin, H., & Stanley, E. R. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209822 · Cited by 370 · see citing works
Mizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., & Cardona, A. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100421 · Cited by 346 · see citing works
Self-citationDigital Multiplexed Gene Expression Analysis Using the NanoString nCounter System
Kulkarni, M. M. (2011) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb25b10s94 · Cited by 309 · see citing works
Huang, D., Shi, F., Jung, S., Pien, G. C., Wang, J., Salazar‐Mather, T. P., He, T. T., Weaver, J. T., Ljunggren, H., Biron, C. A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5465com · Cited by 284 · see citing works
Self-citationExpression of CCR7 in multiple sclerosis: implications for CNS immunity
Kivisäkk, P., Mahad, D. J., Callahan, M. K., Sikora, K., Trebst, C., Tucky, B., Wujek, J., Ravid, R., Staugaitis, S. M., Lassmann, H., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20049 · Cited by 267 · see citing works
Self-citationTrebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242 · see citing works
Self-citationRelationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
Ghebremedhin, E., Tredici, K. D., Vukšić, M., Rüb, U., Thal, D. R., Burbach, G. J., Rosenberger, A., Bickeböller, H., Deller, T., de Vos, R. A. I., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000199572.96472.1c · Cited by 238 · see citing works
Opsonization with C1q and Mannose-Binding Lectin Targets Apoptotic Cells to Dendritic Cells
Nauta, A. J., Castellano, G., Xu, W., Woltman, A. M., Borrias, M. C., Daha, M. R., van Kooten, C., & Roos, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3044 · Cited by 236 · see citing works
Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for Therapy
Steinman, L., Martinꝉ, R., Bernard, C. C. A., Conlon, P. J., & Oksenberg, J. R. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142913 · Cited by 230 · see citing works
Bauer, J., Huitinga, I., Zhao, W., Lassmann, H., Hickey, W. F., & Dijkstra, C. D. (1995) · Glia · doi:10.1002/glia.440150407 · Cited by 226 · see citing works
Donnelly, D. J., Longbrake, E. E., Shawler, T. M., Kigerl, K. A., Lai, W., Tovar, C. A., Ransohoff, R. M., & Popovich, P. G. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2114-11.2011 · Cited by 219 · see citing works
Self-citationThe GAIT system: a gatekeeper of inflammatory gene expression
Mukhopadhyay, R., Jia, J., Arif, A., Ray, P. S., & Fox, P. L. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.03.004 · Cited by 216 · cited 1× · see citing works
“Although often regarded as a housekeeping gene, GAPDH is found in complexes that limit the translation of inflammatory gene transcripts in activated mouse macrophages (Mukhopadhyay et al., 2009; Arif et al., 2012).”
BackgroundLiu, L., Belkadi, A., Darnall, L., Hu, T., Drescher, C., Cotleur, A. C., Padovani-Claudio, D., He, T., Choi, K., Lane, T. E., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2491 · Cited by 214 · see citing works
Self-citationDevelopment and homeostasis of “resident” myeloid cells: the case of the microglia
Gomez Perdiguero, E., Schulz, C., & Geissmann, F. (2013) · Glia · doi:10.1002/glia.22393 · Cited by 182 · see citing works
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G. L., & Aloisi, F. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/65.2.124 · Cited by 176 · see citing works
Isolation of brain and spinal cord mononuclear cells using percoll gradients.
Pino, P., & Cardona, A. (2011) · Journal of Visualized Experiments · doi:10.3791/2348 · Cited by 142 · see citing works
(1994) · PubMed · Cited by 113 · see citing works
Microgliosis: the questions shape the answers
Ransohoff, R. M. (2007) · Nature Neuroscience · doi:10.1038/nn1207-1507 · Cited by 109 · see citing works
Huitinga, I., Damoiseaux, J. G. M. C., Döpp, E. A., et al. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230321 · Cited by 94 · see citing works
Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases
Xu, Y., Li, J., Ferguson, G. D., Mercurio, F., Khambatta, G., Morrison, L., Lopez‐Girona, A., Corral, L. G., Webb, D. R., Bennett, B. L., et al. (2009) · Blood · doi:10.1182/blood-2009-02-200543 · Cited by 87 · see citing works
The immunology of multiple sclerosis
Ransohoff, R. M., Tuohy, V. K., & Lehmann, P. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199406000-00011 · Cited by 84 · see citing works
Self-citationMonocytes regulate T cell migration through the glia limitans during acute viral encephalitis
Savarin, C., Stohlman, S. A., Atkinson, R., Ransohoff, R. M., & Bergmann, C. C. (2010) · Journal of Virology · doi:10.1128/jvi.00051-10 · Cited by 68 · see citing works
Self-citationFu, Y., Frederick, T., Huff, T. B., Goings, G., Miller, S. D., & Cheng, J.-X. (2011) · Journal of Biomedical Optics · doi:10.1117/1.3638180 · Cited by 62 · see citing works
Humoral autoimmunity in multiple sclerosis
Meinl, E., Derfuss, T. J., Krumbholz, M., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.009 · Cited by 59 · see citing works
Heterotrimeric GAIT complex drives transcript-selective translation inhibition in murine macrophages
Arif, A., Chatterjee, P., Moodt, R. A., & Fox, P. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01168-12 · Cited by 53 · see citing works
Isolation of Brain and Spinal Cord Mononuclear Cells Using Percoll Gradients
Pino, P. A., & Cardona, A. E. (2011) · Journal of Visualized Experiments · doi:10.3791/2348-v · Cited by 34 · see citing works
Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?
Desmazières, A., Sol-Foulon, N., & Lubetzki, C. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511434370 · Cited by 24 · see citing works
Flagged first, then by citations
2 of the 51 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · see citing works
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215 · see citing works
Microglia and macrophages in brain homeostasis and disease
Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999 · see citing works
Microglial <scp>M1/M2</scp> polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070 · see citing works
Microglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710 · see citing works
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573 · see citing works
Self-citationiPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154 · see citing works
Mrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I., Heppner, F. L., Kipnis, J., Merkler, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.011 · Cited by 1,010 · see citing works
Developmental and Functional Heterogeneity of Monocytes
Guilliams, M., Mildner, A., & Yona, S. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.005 · Cited by 973 · see citing works
Macrophages: Development and Tissue Specialization
Varol, C., Mildner, A., & Jung, S. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112220 · Cited by 962 · see citing works
Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation
Jordão, M. J. C., Sankowski, R., Brendecke, S. M., Sagar, Locatelli, G., Tai, Y.-H., Tay, T. L., Schramm, E., Armbruster, S., Hagemeyer, N., et al. (2019) · Science · doi:10.1126/science.aat7554 · Cited by 843 · see citing works
Inflammation and neuroprotection in traumatic brain injury.
Corps, K. N., Roth, T. L., & McGavern, D. B. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3558 · Cited by 853 · see citing works
New insights into the multidimensional concept of macrophage ontogeny, activation and function
Ginhoux, F., Schultze, J., Murray, P., Ochando, J., & Biswas, S. (2015) · Nature Immunology · doi:10.1038/ni.3324 · Cited by 745 · see citing works
Dendritic cell migration in health and disease
Worbs, T., Hammerschmidt, S. I., & Förster, R. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.116 · Cited by 826 · see citing works
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 744 · see citing works
Macrophage heterogeneity in tissues: phenotypic diversity and functions
Gordon, S., Plüddemann, A., & Martínez, F. O. (2014) · Immunological Reviews · doi:10.1111/imr.12223 · Cited by 712 · see citing works
Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke
Xiong, X., Liu, L., & Yang, Q. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.001 · Cited by 703 · see citing works
Self-citationCytokine networks in neuroinflammation
Becher, B., Spath, S., & Goverman, J. M. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.123 · Cited by 681 · see citing works
An updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692 · see citing works
Macrophages and cancer: from mechanisms to therapeutic implications
Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 685 · see citing works
Mechanisms of Organ Injury and Repair by Macrophages
Vannella, K. M., & Wynn, T. A. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034356 · Cited by 656 · see citing works
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657 · see citing works
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647 · see citing works
Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
Efthymiou, A. G., & Goate, A. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0184-x · Cited by 562 · see citing works
Sall1 is a transcriptional regulator defining microglia identity and function
Buttgereit, A., Lelios, I., Yu, X., Vrohlings, M., Krakoski, N. R., Gautier, E. L., Nishinakamura, R., Becher, B., & Greter, M. (2016) · Nature Immunology · doi:10.1038/ni.3585 · Cited by 570 · see citing works
Neuroimmune mechanisms of depression
Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4113 · Cited by 585 · see citing works
GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
Becher, B., Tugues, S., & Greter, M. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.026 · Cited by 593 · see citing works
Inefficient clearance of myelin debris by microglia impairs remyelinating processes
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M. G., Yong, V. W., Stys, P. K., Tremblay, M.-È., & Rivest, S. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141656 · Cited by 595 · see citing works
Maida, C. D., Norrito, R. L., Daidone, M., Tuttolomondo, A., & Pinto, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186454 · Cited by 594 · see citing works
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Hemmer, B., Kerschensteiner, M., & Korn, T. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70305-9 · Cited by 589 · see citing works
Glioblastoma: defining tumor niches
Hambardzumyan, D., & Bergers, G. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.009 · Cited by 522 · see citing works
The epidemiology of multiple sclerosis
Goodin, D. S. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 517 · see citing works
The microbiome: a key regulator of stress and neuroinflammation
Rea, K., Dinan, T. G., & Cryan, J. F. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.001 · Cited by 508 · see citing works
Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Voet, S., Prinz, M., & van Loo, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.005 · Cited by 503 · see citing works
CNS inflammation and neurodegeneration
Chitnis, T., & Weiner, H. L. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90609 · Cited by 484 · see citing works
Self-citationWang, M., Pan, W., Xu, Y., Zhang, J., Wan, J., & Jiang, H. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s350109 · Cited by 461 · see citing works
McQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0297-x · Cited by 449 · see citing works
Neuroinflammation and Perioperative Neurocognitive Disorders
Subramaniyan, S., & Terrando, N. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004053 · Cited by 453 · see citing works
Balancing the immune response in the brain: IL-10 and its regulation
Lobo‐Silva, D., Carriche, G. M., Castro, A. G., Roque, S., & Saraiva, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0763-8 · Cited by 430 · see citing works
Macrophages at CNS interfaces: Ontogeny and function in health and disease
Kierdorf, K., Masuda, T., Jordão, M. J. C., & Prinz, M. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0201-x · Cited by 416 · see citing works
Cronk, J. C., Filiano, A. J., Louveau, A., Marin, I., Marsh, R., Ji, E., Goldman, D. H., Smirnov, I., Geraci, N., Acton, S., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180247 · Cited by 412 · see citing works
Amit, I., Winter, D. R., & Jung, S. (2015) · Nature Immunology · doi:10.1038/ni.3325 · Cited by 405 · see citing works
Does niche competition determine the origin of tissue-resident macrophages?
Guilliams, M., & Scott, C. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.42 · Cited by 409 · see citing works
Immune cell regulation of glia during CNS injury and disease
Greenhalgh, A. D., David, S., & Bennett, F. C. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0263-9 · Cited by 398 · see citing works
Immune and neuroendocrine mechanisms of stress vulnerability and resilience
Ménard, C., Pfau, M. L., Hodes, G. E., & Russo, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.90 · Cited by 374 · see citing works
The pro-remyelination properties of microglia in the central nervous system
Lloyd, A. F., & Miron, V. E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0184-2 · Cited by 381 · see citing works
Macrophage biology in the peripheral nervous system after injury
Zigmond, R. E., & Echevarría, F. D. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.001 · Cited by 369 · see citing works
Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
van Kesteren, C. F. M. G., Gremmels, H., de Witte, L. D., Hol, E. M., Gool, A. R. V., Falkai, P., Kahn, R. S., & Sommer, I. E. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.4 · Cited by 367 · see citing works
Varvel, N. H., Neher, J. J., Bosch, A., Wang, W., Ransohoff, R. M., Miller, R. J., & Dingledine, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604263113 · Cited by 357 · see citing works
Self-citationThe Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
Ma, W., Gao, F., Gu, K., & Chen, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01140 · Cited by 360 · see citing works
Więckowska-Gacek, A., Mietelska-Porowska, A., Wydrych, M., & Wojda, U. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101397 · Cited by 343 · see citing works
The role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 339 · see citing works
Ajami, B., Samusik, N., Wieghofer, P., Ho, P. P., Crotti, A., Bjornson, Z., Prinz, M., Fantl, W. J., Nolan, G. P., & Steinman, L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0100-x · Cited by 338 · see citing works
The Immune Response in Multiple Sclerosis
Murúa, S. R., Farez, M., & Quintana, F. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052920-040318 · Cited by 347 · see citing works
Yan, Z., Gibson, S. A., Buckley, J. A., Qin, H., & Benveniste, E. N. (2018) · Clinical Immunology · doi:10.1016/j.clim.2016.09.014 · Cited by 318 · see citing works
Myeloid Cells in the Central Nervous System
Herz, J., Filiano, A. J., Wiltbank, A. T., Yogev, N., & Kipnis, J. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.007 · Cited by 331 · see citing works
Microglia in Health and Disease
Ransohoff, R. M., & Khoury, J. E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020560 · Cited by 303 · see citing works
Self-citationPhagocytosis in the Brain: Homeostasis and Disease
Galloway, D. A., Phillips, A. E. M., Owen, D. R., & Moore, C. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00790 · Cited by 304 · see citing works
Functional differences between microglia and monocytes after ischemic stroke
Ritzel, R. M., Patel, A. R., Grenier, J. M., Crapser, J., Verma, R., Jellison, E. R., & McCullough, L. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0329-1 · Cited by 295 · see citing works
Microglia Versus Myeloid Cell Nomenclature during Brain Inflammation
Greter, M., Lelios, I., & Croxford, A. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00249 · Cited by 273 · see citing works
Microglia in depression: current perspectives
Jia, X., Gao, Z., & Hu, H. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1815-6 · Cited by 283 · see citing works
The Kaleidoscope of Microglial Phenotypes
Dubbelaar, M. L., Kracht, L., Eggen, B. J. L., & Boddeke, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01753 · Cited by 271 · see citing works
Tissue macrophage identity and self‐renewal
Gentek, R., Molawi, K., & Sieweke, M. H. (2014) · Immunological Reviews · doi:10.1111/imr.12224 · Cited by 277 · see citing works
TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage
Taylor, R. A., Chang, C.-F., Goods, B. A., Hammond, M. D., Grory, B. M., Ai, Y., Steinschneider, A. F., Renfroe, S. C., Askenase, M. H., McCullough, L. D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88647 · Cited by 277 · see citing works
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system
Rawji, K. S., Mishra, M. K., Michaels, N. J., Rivest, S., Stys, P. K., & Yong, V. W. (2016) · Brain · doi:10.1093/brain/awv395 · Cited by 252 · see citing works
Microbes, immunity, and behavior: psychoneuroimmunology meets the microbiome
Dinan, T. G., & Cryan, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.103 · Cited by 246 · see citing works
Aging Microglia—Phenotypes, Functions and Implications for Age-Related Neurodegenerative Diseases
Spittau, B. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00194 · Cited by 258 · see citing works
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
Allen Reish, H. E., & Standaert, D. G. (2015) · Journal of Parkinson’s Disease · doi:10.3233/jpd-140491 · Cited by 244 · see citing works
O’Koren, E. G., Mathew, R., & Saban, D. R. (2016) · Scientific Reports · doi:10.1038/srep20636 · Cited by 220 · see citing works
Ontogeny and Polarization of Macrophages in Inflammation: Blood Monocytes Versus Tissue Macrophages
Dey, A., Allen, J. N., & Hankey, G. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00683 · Cited by 245 · see citing works
The Ischemic Environment Drives Microglia and Macrophage Function
Fumagalli, S., Perego, C., Pischiutta, F., Zanier, E. R., & Simoni, M. G. D. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00081 · Cited by 245 · see citing works
Neurosteroids as regulators of neuroinflammation
Yılmaz, C., Karali, K., Fodelianaki, G., Gravanis, A., Chavakis, T., Charalampopoulos, I., & Alexaki, V. I. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100788 · Cited by 245 · see citing works
Pöyhönen, S., Er, Ş., Domanskyi, A., & Airavaara, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00486 · Cited by 242 · see citing works
Harms, A. S., Thome, A. D., Yan, Z., Schonhoff, A. M., Williams, G. P., Li, X., Liu, Y., Qin, H., Benveniste, E. N., & Standaert, D. G. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.010 · Cited by 236 · see citing works
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation
Schwartz, M., & Deczkowska, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.001 · Cited by 246 · see citing works
Microglial activation and progressive brain changes in schizophrenia
Laskaris, L., Biase, M. A. D., Everall, I., Chana, G., Christopoulos, A., Skafidas, E. S., Cropley, V., & Pantelis, C. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13364 · Cited by 227 · see citing works
Kamphuis, W., Kooijman, L., Schetters, S., Orre, M., & Hol, E. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.007 · Cited by 209 · see citing works
Natrajan, M. S., de la Fuente, A. G., Crawford, A. H., Linehan, E., Núñez, V., Johnson, K. R., Wu, T., Fitzgerald, D. C., Ricote, M., Bielekova, B., et al. (2015) · Brain · doi:10.1093/brain/awv289 · Cited by 217 · see citing works
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216 · see citing works
“on their differential expression of RFP and GFP [355].”
BackgroundMethodInfluentialP2X ion channel receptors and inflammation
Burnstock, G. (2016) · Purinergic Signalling · doi:10.1007/s11302-015-9493-0 · Cited by 215 · see citing works
Werner, Y., Mass, E., Ashok Kumar, P., Ulas, T., Händler, K., Horne, A., Klee, K., Lupp, A., Schütz, D., Saaber, F., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0585-y · Cited by 208 · see citing works
Greenhalgh, A. D., Zarruk, J. G., Healy, L. M., Jesudasan, S. J. B., Jhelum, P., Salmon, C. K., Formanek, A., Russo, M. V., Antel, J. P., McGavern, D. B., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005264 · Cited by 211 · see citing works
A basic overview of multiple sclerosis immunopathology
Grigoriadis, N., & Pesch, V. V. (2015) · European Journal of Neurology · doi:10.1111/ene.12798 · Cited by 204 · see citing works
Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations
Liu, Q., Jin, W.-N., Liu, Y., Shi, K., Sun, H., Zhang, F., Zhang, C., Gonzales, R. J., Sheth, K. N., Cava, A. L., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.015 · Cited by 207 · see citing works
The role of microglia in multiple sclerosis
Luo, C., Jian, C., Liao, Y., Huang, Q., Wu, Y., Liu, X., Zou, D., & Wu, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s140634 · Cited by 206 · see citing works
Tian, D., Peng, J., Murugan, M., Feng, L.-J., Liu, J., Eyo, U. B., Zhou, L., Mogilevsky, R., Wang, W., & Wu, L. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0315-17.2017 · Cited by 202 · see citing works
Komuczki, J., Tuzlak, S., Friebel, E., Hartwig, T., Spath, S., Rosenstiel, P., Waisman, A., Opitz, L., Oukka, M., Schreiner, B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.006 · Cited by 201 · see citing works
DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
Kular, L., Liu, Y., Ruhrmann, S., Zheleznyakova, G. Y., Marabita, F., Gómez-Cabrero, D., James, T., Ewing, E., Lindén, M., Górnikiewicz, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04732-5 · Cited by 203 · see citing works
M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?
Moehle, M. S., & West, A. B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.018 · Cited by 198 · see citing works
Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages
Stamatiades, E. G., Tremblay, M., Bohm, M., Crozet, L., Bisht, K., Kao, D., Coelho, C., Fan, X., Yewdell, W. T., Davidson, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.058 · Cited by 199 · see citing works
Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases
Song, G. J., & Suk, K. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00139 · Cited by 199 · see citing works
Sevenich, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00697 · Cited by 199 · see citing works
P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis
Zabala, A., Vazquez‐Villoldo, N., Rissiek, B., Gejo, J., Martin, A., Palomino, A., Perez‐Samartín, A., Pulagam, K. R., Lukowiak, M., Capetillo‐Zarate, E., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708743 · Cited by 192 · see citing works
The role of microglia in viral encephalitis: a review
Chen, Z., Zhong, D., & Li, G. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1443-2 · Cited by 189 · see citing works
Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3
Zhang, X., Wang, Y., Yuan, J., Li, N., Pei, S.-Y., Xu, J., Luo, X., Mao, C.-M., Liu, J.-L., Yu, T., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171417 · Cited by 179 · see citing works
Myeloid cells — targets of medication in multiple sclerosis
Mishra, M. K., & Yong, V. W. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.110 · Cited by 182 · see citing works
Andonegui, G., Zelinski, E. L., Schubert, C. L., Knight, D., Craig, L. A., Winston, B. W., Spanswick, S. C., Petri, B., Jenne, C. N., Sutherland, J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99364 · Cited by 177 · see citing works
Astrocytic phagocytosis is a compensatory mechanism for microglial dysfunction
Konishi, H., Okamoto, T., Hara, Y., Komine, O., Tamada, H., Maeda, M., Osako, F., Kobayashi, M., Nishiyama, A., Kataoka, Y., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020104464 · Cited by 179 · see citing works
Shemer, A., Scheyltjens, I., Frumer, G. R., Kim, J.-S., Grozovski, J., Ayanaw, S., Dassa, B., Van Hove, H., Chappell-Maor, L., Boura-Halfon, S., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.018 · Cited by 175 · see citing works
- Authors
- Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., Kidd, G., Zorlu, M. M., Sun, N., Hu, W., Liu, L., Lee, J.-C., Taylor, S. E., Uehlein, L., Dixon, D., Gu, J., Floruta, C. M., Zhu, M., Charo, I. F., Weiner, H. L., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- Brigham and Women's Hospital (US)
- Vanderbilt University (US)
- Case Western Reserve University (US)
- University of California, San Francisco (US)
- Corresponding author
- Ransohoff, Richard M.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2014-07-07
- Volume
- 211
- Issue
- 8
- Pages
- 1533-1549
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4113947
- OpenAlex
- W2159443316
- Cited by
- 855
- References
- 51
- Citations by year
- 2026: 22 · 2025: 46 · 2024: 52 · 2023: 42 · 2022: 58 · 2021: 103 · 2020: 75 · 2019: 71 · 2018: 83 · 2017: 91 · 2016: 93 · 2015: 76 · 2014: 15
- FWCI
- 60.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc-sa)
- PubMed Central (submittedVersion, cc-by-nc-sa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- microglia, monocytes, macrophages, multiple sclerosis, experimental autoimmune encephalomyelitis, demyelination, monocyte-derived macrophages, nodes of Ranvier
- MeSH terms
- CX3C Chemokine Receptor 1, Animals, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Gene Expression Regulation, Homeostasis, Humans, Inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-16.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-16.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review